ReviewJournal of molecular neuroscience : MN2018

CRISPR/Cas9, the Powerful New Genome-Editing Tool for Putative Therapeutics in Obesity.

María José Franco-Tormo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.